Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Latest updates to the ESMO bone health guidelines

Prof Robert Coleman - University of Sheffield, Sheffield, UK

Latest updates to the ESMO bone health guidelines ( Prof Robert Coleman - University of Sheffield, Sheffield, UK )

CheckMate 649: Nivolumab plus chemotherapy for gastric and oesophageal cancers

Prof Markus Möhler - Universitätsmedizin Mainz, Mainz, Germany

CheckMate 649: Nivolumab plus chemotherapy for gastric and oesophageal cancers ( Prof Markus Möhler - Universitätsmedizin Mainz, Mainz, Germany )

AMG 160: A PSMA-targeted, bispecific T-cell engager immune therapy for mCRPC

Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia

AMG 160: A PSMA-targeted, bispecific T-cell engager immune therapy for mCRPC ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia )

Estimate of the 2-year oncology workload generated by each new patient: A real...

Dr Silvio Ken Garattini - University of Udine, Udine, Italy

Estimate of the 2-year oncology workload generated by each new patient: A real-world study ( Dr Silvio Ken Garattini - University of Udine, Udine, Italy )

Amivantamab lazertinib and other novel combinations in EGFR positive advanced...

Dr Alex Spira and Dr Joshua Sabari

Amivantamab lazertinib and other novel combinations in EGFR positive advanced NSCLC ( Dr Alex Spira and Dr Joshua Sabari )

Impact of COVID-19 pandemic on cancer care: A global collaborative study

Prof Abdul-Rahman Jazieh - King Saud bin Abdulaziz University, Riyadh, Saudi...

Impact of COVID-19 pandemic on cancer care: A global collaborative study ( Prof Abdul-Rahman Jazieh - King Saud bin Abdulaziz University, Riyadh, Saudi Arabia )

MonarchE: Abemaciclib plus endocrine therapy in high-risk early breast cancer

Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK

MonarchE: Abemaciclib plus endocrine therapy in high-risk early breast cancer ( Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK )

LungART: Radiotherapy after surgery for patients with non small cell lung cancer

Dr Cécile Le Péchoux - Gustave Roussy Cancer Campus, Villejuif, CEDEX, France

LungART: Radiotherapy after surgery for patients with non small cell lung cancer ( Dr Cécile Le Péchoux - Gustave Roussy Cancer Campus, Villejuif, CEDEX, France )

Personalised molecularly matched therapies for carcinomas of unknown primary

Dr Jacob Adashek - University of South Florida, Tampa, USA

Personalised molecularly matched therapies for carcinomas of unknown primary ( Dr Jacob Adashek - University of South Florida, Tampa, USA )

Impact of COVID-19 on oncology professionals

Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK

Impact of COVID-19 on oncology professionals ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )

SOLO-1: Olaparib or placebo for patients with newly diagnosed BRCA-mutated...

Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK

SOLO-1: Olaparib or placebo for patients with newly diagnosed BRCA-mutated advanced ovarian cancer ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )

Comparing real world evidence to phase III data on apalutamide for nmCRPC

Prof Heather Payne and Prof Stéphane Oudard

Comparing real world evidence to phase III data on apalutamide for nmCRPC ( Prof Heather Payne and Prof Stéphane Oudard )

More from ecancer